Amrutanjan Health Care Limited
NSE: AMRUTANJAN BSE: AMRUTANJAN
NSE
654.50
-17.15 (-2.55%)
Prev Close
671.65
Open Price
671.65
Volume
11,177
Today Low / High
651 / 676.7
52 WK Low / High
559.95 / 862.6
Range
622 - 687
BSE
656.65
-15.85 (-2.36%)
Prev Close
672.5
Open Price
666.05
Volume
3,627
Today Low / High
652.05 / 673
52 WK Low / High
548.05 / 861.4
Range
624 - 689
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 654.5 (target range: 622 - 687), reflecting a change of -17.15 (-2.55341%). On the BSE, it is listed at 656.65 (target range: 624 - 689), showing a change of -15.85 (-2.35688%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
25 Apr
671.65
-2.55%
24 Apr
670.00
0.25%
23 Apr
683.65
-1.97%
22 Apr
673.20
1.55%
21 Apr
678.20
-0.69%
17 Apr
685.40
-1.79%
16 Apr
668.85
2.47%
15 Apr
636.95
5.11%
11 Apr
640.90
-1.38%
09 Apr
632.00
0.62%
08 Apr
622.80
0.73%
07 Apr
620.00
-1.27%
04 Apr
659.05
-2.51%
03 Apr
641.10
3.87%
02 Apr
635.10
1.63%
01 Apr
661.10
-2.65%
28 Mar
633.40
2.95%
Amrutanjan Health Care Limited Graph
Amrutanjan Health Care Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Amrutanjan Health Care Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 654.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 656.65 | 663.22 | 596.89 - 729.54 |
| 669.78 | 535.83 - 803.74 | ||
| 676.35 | 473.44 - 879.25 | ||
| Bearish Scenario | 656.65 | 650.08 | 585.08 - 715.09 |
| 643.52 | 514.81 - 772.22 | ||
| 636.95 | 445.87 - 828.04 |
Overview of Amrutanjan Health Care Limited
ISIN
INE098F01031
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
23,728
Market Cap
19,131,427,700
Last Dividend
4.6
Official Website
IPO Date
2009-11-05
DCF Diff
-136.94
DCF
791
Financial Ratios Every Investor Needs
Stock Dividend of AMRUTANJAN
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-02-18 | February 18, 25 | 1 | 1 | 2025-02-18 | 2025-03-14 | |
| 2024-11-22 | November 22, 24 | 1 | 1 | 2024-11-22 | 2024-12-12 | |
| 2024-09-13 | September 13, 24 | 2.6 | 2.6 | 2024-09-16 | 2024-10-23 | |
| 2024-02-20 | February 20, 24 | 1 | 1 | 2024-02-20 | 2024-03-10 | |
| 2023-11-23 | November 23, 23 | 1 | 1 | 2023-11-23 | 2023-12-10 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 421.23 Cr | 211.83 Cr | 209.40 Cr | 0.4971 | 0.00 Cr | 26.27 Cr | 62.10 Cr | 44.97 Cr | 15.50 | 68.16 Cr | 0.1068 |
| 2023-03-31 | 379.54 Cr | 181.98 Cr | 197.56 Cr | 0.5205 | 1.20 Cr | 4.46 Cr | 41.85 Cr | 39.83 Cr | 13.65 | 59.08 Cr | 0.1050 |
| 2022-03-31 | 405.45 Cr | 180.46 Cr | 224.98 Cr | 0.5549 | 1.13 Cr | 2.73 Cr | 79.84 Cr | 67.19 Cr | 23.00 | 94.70 Cr | 0.1657 |
| 2021-03-31 | 331.55 Cr | 140.19 Cr | 191.36 Cr | 0.5772 | 0.87 Cr | 2.44 Cr | 71.79 Cr | 61.19 Cr | 20.94 | 86.17 Cr | 0.1846 |
| 2020-03-31 | 260.72 Cr | 117.07 Cr | 143.65 Cr | 0.5510 | 1.05 Cr | 2.44 Cr | 26.78 Cr | 25.08 Cr | 8.58 | 39.15 Cr | 0.0962 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 25.76 Cr | 366.87 Cr | 78.38 Cr | 288.4883 Cr | 1.73 Cr | -24.04 Cr | 28.90 Cr | 49.54 Cr | 1.06 Cr | 0.00 Cr | 11.55 Cr | 69.9185 Cr |
| 2023-03-31 | 4.90 Cr | 362.09 Cr | 71.32 Cr | 290.7719 Cr | 0.91 Cr | -3.99 Cr | 28.83 Cr | 47.55 Cr | 7.22 Cr | -1.77 Cr | 43.05 Cr | 63.0121 Cr |
| 2022-03-31 | 83.48 Cr | 349.87 Cr | 84.74 Cr | 265.1238 Cr | 0.88 Cr | -82.60 Cr | 26.00 Cr | 43.47 Cr | 9.95 Cr | -1.70 Cr | 22.31 Cr | 77.4730 Cr |
| 2021-03-31 | 130.70 Cr | 274.27 Cr | 58.71 Cr | 215.5647 Cr | 1.34 Cr | -129.36 Cr | 17.46 Cr | 23.32 Cr | 5.94 Cr | -1.80 Cr | 20.60 Cr | 52.1034 Cr |
| 2020-03-31 | 27.16 Cr | 205.35 Cr | 45.92 Cr | 159.4256 Cr | 1.69 Cr | -25.46 Cr | 23.72 Cr | 25.57 Cr | -0.58 Cr | -2.17 Cr | 45.13 Cr | 39.0627 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 27.9106 Cr | 19.1650 Cr | -48.2664 Cr | 21.1929 Cr | -1.1908 Cr | 3.7120 Cr | -6.7177 Cr | 44.9726 Cr | 0.0000 Cr | -13.3863 Cr | -0.0796 Cr |
| 2023-03-31 | 19.2181 Cr | -2.4750 Cr | -14.0265 Cr | 10.2914 Cr | 2.7166 Cr | 4.9028 Cr | -8.9267 Cr | 53.6454 Cr | 0.0000 Cr | -14.4091 Cr | -2.8244 Cr |
| 2022-03-31 | 52.1956 Cr | -36.2119 Cr | -16.7024 Cr | 28.7322 Cr | -0.7189 Cr | 2.1862 Cr | -23.4634 Cr | 90.5766 Cr | 0.0000 Cr | -12.4765 Cr | -8.5421 Cr |
| 2021-03-31 | 89.7629 Cr | -87.7608 Cr | -6.3167 Cr | 87.8022 Cr | -4.3155 Cr | 2.9051 Cr | -1.9607 Cr | 81.9045 Cr | 0.0000 Cr | -4.6770 Cr | 6.2573 Cr |
| 2020-03-31 | 18.1761 Cr | -13.8502 Cr | -11.6898 Cr | 15.6317 Cr | -7.3649 Cr | 7.2206 Cr | -2.5444 Cr | 34.4539 Cr | 0.0000 Cr | -11.1003 Cr | -9.1391 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 122.75 Cr | 55.80 Cr | 66.95 Cr | 0.5454 | 21.68 Cr | 19.25 Cr | 6.66 | 27.71 Cr | 0.1568 |
| 2024-09-30 | 109.92 Cr | 54.41 Cr | 55.51 Cr | 0.5050 | 11.95 Cr | 11.80 Cr | 4.08 | 17.65 Cr | 0.1073 |
| 2024-06-30 | 83.74 Cr | 59.45 Cr | 24.28 Cr | 0.2900 | 1.96 Cr | 4.62 Cr | 1.60 | 8.00 Cr | 0.0551 |
| 2024-03-31 | 100.22 Cr | 51.10 Cr | 49.12 Cr | 0.4901 | 11.57 Cr | 13.66 Cr | 4.35 | 16.24 Cr | 0.1363 |
| 2023-12-31 | 116.99 Cr | 56.57 Cr | 60.42 Cr | 0.5165 | 23.76 Cr | 17.45 Cr | 6.04 | 25.34 Cr | 0.1491 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.07 Cr | 222.30 Cr | 229.37 Cr | 0.00 Cr | 32.63 Cr | 305.60 Cr | 49.14 Cr | 382.60 Cr | 84.81 Cr |
| 2024-03-31 | 25.76 Cr | 0.00 Cr | 211.31 Cr | 0.00 Cr | 28.90 Cr | 295.68 Cr | 49.54 Cr | 366.87 Cr | 78.38 Cr |
| 2023-12-31 | -204.87 Cr | 409.75 Cr | 204.87 Cr | 0.00 Cr | 0.00 Cr | 204.87 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 9.26 Cr | 195.61 Cr | 204.87 Cr | 33.49 Cr | 30.89 Cr | 275.30 Cr | 47.95 Cr | 355.05 Cr | 93.05 Cr |
| 2023-06-30 | -192.56 Cr | 385.12 Cr | 192.56 Cr | 0.00 Cr | 0.00 Cr | 192.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 13.66 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 17.45 Cr | 3.15 Cr | 0.00 Cr | 0.00 Cr | 3.15 Cr | 53.24 Cr | 50.09 Cr | 0.00 Cr | 3.15 Cr |
| 2023-09-30 | 6.85 Cr | 3.11 Cr | 0.00 Cr | 0.00 Cr | 3.11 Cr | 50.09 Cr | 46.98 Cr | 0.00 Cr | 3.11 Cr |
| 2023-06-30 | 7.01 Cr | 2.78 Cr | 0.00 Cr | 0.00 Cr | 2.78 Cr | 10.44 Cr | 7.66 Cr | 0.00 Cr | 2.78 Cr |
| 2023-03-31 | 12.70 Cr | 0.44 Cr | 0.00 Cr | 0.00 Cr | 0.44 Cr | 7.66 Cr | 7.22 Cr | 0.00 Cr | 0.44 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2018-04-13 | April 13, 18 | 2:1 |
| 2012-10-25 | October 25, 12 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,787.40 | ₹4,288,473,072,000.00 | ₹2,036,791.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,012.50 | ₹1,596,132,362,500.00 | ₹964,268.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,238.90 | ₹1,096,189,510,500.00 | ₹330,175.00 |
| Mankind Pharma Limited | MANKIND | ₹2,557.50 | ₹1,055,169,564,900.00 | ₹459,204.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,174.80 | ₹978,741,175,896.00 | ₹1,286,033.00 |
| Lupin Limited | LUPIN | ₹2,019.60 | ₹922,078,674,000.00 | ₹725,763.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹859.65 | ₹865,005,619,500.00 | ₹1,090,178.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,220.10 | ₹708,636,520,200.00 | ₹779,791.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,033.50 | ₹601,830,427,500.00 | ₹78,195.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,360.70 | ₹383,973,211,600.00 | ₹663,941.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,419.00 | ₹360,005,976,000.00 | ₹136,095.00 |
| Laurus Labs Limited | LAURUSLABS | ₹625.65 | ₹337,383,639,450.00 | ₹7,085,459.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,676.00 | ₹334,264,512,000.00 | ₹68,055.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,143.20 | ₹291,018,708,000.00 | ₹182,742.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,573.70 | ₹244,988,894,900.00 | ₹209,724.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,397.60 | ₹227,080,650,400.00 | ₹530,470.00 |
| Piramal Enterprises Limited | PEL | ₹981.20 | ₹221,239,013,600.00 | ₹539,403.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,725.00 | ₹218,125,000,000.00 | ₹18,384.00 |
| Eris Lifesciences Limited | ERIS | ₹1,468.20 | ₹199,914,516,600.00 | ₹159,295.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹875.45 | ₹172,081,078,350.00 | ₹134,690.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹889.25 | ₹159,273,567,500.00 | ₹2,751,932.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,300.00 | ₹157,807,770,000.00 | ₹51,065.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹910.00 | ₹144,945,710,000.00 | ₹435,484.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,806.70 | ₹137,330,338,390.00 | ₹113,214.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹452.55 | ₹109,763,287,200.00 | ₹1,470,230.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,063.50 | ₹84,051,061,900.00 | ₹14,035.00 |
| FDC Limited | FDC | ₹425.60 | ₹69,291,936,000.00 | ₹160,693.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹735.15 | ₹66,623,711,252.00 | ₹289,105.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹680.85 | ₹66,580,934,265.00 | ₹242,907.00 |
| Strides Pharma Science Limited | STAR | ₹653.45 | ₹60,223,716,315.00 | ₹347,801.00 |
| Innova Captab Limited | INNOVACAP | ₹884.20 | ₹50,598,283,106.00 | ₹56,782.00 |
| Hikal Limited | HIKAL | ₹395.05 | ₹48,710,060,050.00 | ₹859,861.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹149.77 | ₹48,603,659,940.00 | ₹946,025.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹617.15 | ₹43,450,939,470.00 | ₹53,930.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹808.55 | ₹41,008,928,305.00 | ₹93,543.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,244.30 | ₹37,118,477,700.00 | ₹18,445.00 |
| Sequent Scientific Limited | SEQUENT | ₹148.12 | ₹37,074,732,240.00 | ₹656,813.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹363.75 | ₹36,476,122,500.00 | ₹110,427.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹58.82 | ₹32,230,654,280.00 | ₹16,857,864.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹350.80 | ₹32,017,516,000.00 | ₹151,977.00 |
| Suven Life Sciences Limited | SUVEN | ₹135.99 | ₹29,655,883,260.00 | ₹895,506.00 |
| Alembic Limited | ALEMBICLTD | ₹101.51 | ₹26,065,940,718.00 | ₹728,399.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹508.85 | ₹25,657,912,488.00 | ₹81,113.00 |
Key Executives
Chief Marketing Officer
Mani Bhagavatheeswaran
Gender: Not Specified
Year Born:
Chief Financial Officer
Mr. N. Swaminathan
Gender: male
Year Born:
Compliance Officer & Company Secretary
Mr. Mahalingam Srinivasan
Gender: male
Year Born:
Chief Sales Officer
R. Narayanan
Gender: Not Specified
Year Born:
Executive Chairman & MD
Mr. Sambhu Prasad Sivalenka
Gender: male
Year Born: 1974
Chief Operating Officer of Supply Chain & Product Delivery
Mr. S. Jeyakanth
Gender: male
Year Born:
FAQs about Amrutanjan Health Care Limited
Who is the CEO of the company?
The CEO is Mr. Sambhu Prasad Sivalenka.
What is the current market price of the stock?
The current price is ₹654.50.
What is the 52-week price range?
The range is ₹559.95-862.6.
What is the market capitalization of the company?
The market capitalization is ₹1,913.14 crores.
What is the dividend yield?
The dividend yield is 0.70%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 38.35.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Amrutanjan Health Care Limited (ISIN: INE098F01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,913.14 crores and an average daily volume of 23,728 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹4.6.